期刊文献+

散发性甲状腺髓样癌规范与非规范手术的效果观察 被引量:9

Comparison of Outcome of Standarized or Non-Standarized Operation in Treatment of Sporadic Medullary Thyroid Carcinoma
原文传递
导出
摘要 目的探讨规范与非规范手术治疗散发性甲状腺髓样癌的效果和预后。方法回顾性分析我院2000年1月至2013年3月期间收治的26例甲状腺髓样癌患者的临床资料。按手术方式分为非规范化手术组和规范化手术组(即双侧甲状腺全切除+淋巴结清扫术)。分析2组患者的术后生化治愈、喉返神经和甲状旁腺损伤情况。结果非规范化手术组和规范化手术组患者的1年生化治愈率比较,差异无统计学意义(84.21%比100%,χ2=1.249 4,P>0.05),1年复发率分别为15.79%和0,规范化手术组的5年生化治愈率明显高于非规范化手术组,差异有统计学意义(100%比16.67%,χ2=4.444 4,P<0.05),5年复发率分别为0和83.33%。2组术后喉返神经损伤率(χ2=0.070 8,P>0.05)及甲状旁腺功能低下发生率(χ2=2.722 7,P>0.05)比较差异均无统计学意义。结论散发性甲状腺髓样癌行规范化手术可提高5年生化治愈率,减少复发,且并未增加术后喉返神经和甲状旁腺的损伤率。 Objective To investigate the effect of surgery and influence of posttreatment with non-standardized and standardized operation by reviewing and analyzing the sporadic medullary thyroid carcinoma operation cases. Methods The clinical data of 26 patients with sporadic medullary thyroid carcinoma treated by surgery from January 2000 to March 2013 in this hospital were analyzed retrospectively. These patients were divided into non-standardized operation group and standardized operation group (total thyroidectomy with lymph node dissection) according to the operation models. The biochemical cure rate, the complication rates of recurrent laryngeal nerve injury and hypopara- thyroidism of these two groups were investigated and compared. Results The 1-year biochemical cure rate had no statistical difference between the non-standardized operation group and standardized operation group (84. 21% versus 100%,x^2=1. 249 4, P〉0. 05), the 1-year recurrence rate was 15.79% and 0, respectively. The 5-year biochemical cure rate of the standardized operation group was significantly higher than that of the non-standardized operation group (100% versus 16.67%,x^2=4. 444 4, P〈0. 05). The 5-year recurrence rate was 0 and 83.33%, respectively. However, there was no obvious difference between the two groups on the injury rate of recurrent laryngeal nerve (x^2=0. 070 8, P〉0. 05), as well as the rate ofhypoparathyroidism (x^2=2. 722 7, P〉0. 05). Conclusions Compared with the non-standardized model, the standardized operation model (total thyroidectomy with lymph node dissection) shows a higher cure rate and a lower recurrent rate, and it does not increase the complication rates of hypoparathyroidism and recurrent laryngeal nerve injury.
出处 《中国普外基础与临床杂志》 CAS 2014年第11期1408-1412,共5页 Chinese Journal of Bases and Clinics In General Surgery
关键词 甲状腺髓样癌 规范手术 并发症 Medullary thyroid neoplasm Standardized operation Complications
  • 相关文献

参考文献5

二级参考文献35

  • 1李正江,苗绪学,唐平章,徐震刚,张德超.甲状腺癌纵隔淋巴结转移的外科处理[J].中华肿瘤杂志,2006,28(2):145-147. 被引量:13
  • 2李树玲.我国甲状腺癌外科现状与展望[J].临床外科杂志,2006,14(3):129-130. 被引量:46
  • 3刘跃武,高维生,唐伟松.应更好地规范甲状腺癌的初次手术[J].中国普外基础与临床杂志,2006,13(3):254-255. 被引量:14
  • 4Brunt LM, Samuel A, Wells JR. Advances in the diagnosis and treatment of medullary thyroid carcinoma. Sur Clin Nor Am, 1987, 67:263-279.
  • 5Pelizzo MR, Boschin IM, Bernante P, et al. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 57 year experience on 157 patients. Eur J Surg Oncol,2007,33: 493- 497.
  • 6van Heerden JA, Grant CS, Gharib H, et al. Long - term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg, 1990, 212:395- 400.
  • 7Frates MC, Benson CB, Charhoneaff JW, et M. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement [J]. Radiology, 2005,237 (3):794-800.
  • 8Haymarl MR, Repplingcr DJ, Leverson GE, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage [J]. J Clin Endocrinol Metab ,2008,93(3): 809-814.
  • 9Layfield LJ, Cibas ES, Gharib H, et al. Thyroid aspiration cytology: current status [J]. CA Cancer J Clin ,2009,59(2):99-110.
  • 10Dora JM, Canalli MH, Capp C, et al. Normal perioperative serum ealeitonin levels in patients with advanced medullary thyroid carcinoma: ease report and review of the literature. Thyroid, 2008,18 : 895-899.

共引文献58

同被引文献84

  • 1朱永学,王弘士,吴毅,嵇庆海,黄彩萍.甲状腺乳头状癌Ⅵ区淋巴结的归属[J].中华外科杂志,2004,42(14):867-869. 被引量:112
  • 2周瑜琳,赵咏桔,成昌友,赵铁耘,殷志强,洪洁,张翼飞,顾丽群,汤正义,崔斌,宁光.五个多发性内分泌肿瘤2B家系的临床分析和RET原癌基因突变研究[J].中华内分泌代谢杂志,2006,22(6):549-553. 被引量:14
  • 3Cancer of the Thyroid Invasive:Trends in SEER Incidence and U.S.Mortality Using the Joinpoint Regression Program,1975-2011.(SEER) Stat version 8.1.2 Rate Session.Access the SEER 18 database at www.seer.cancer.gov.
  • 4Schlumberger M,Pacini F.Thyroid tumors.Paris:Edition Nucleon.2006:313-340.
  • 5Wells SA Jr,Asa SL,Dralle H,et al.American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma.Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.Thyroid ,2015,25(6):567-610.
  • 6Brandi ML,Gagel RF,Angeli A,et al.Guidelines for diagnosis and therapy of MEN type 1 and type 2.J Clin Endocrinol Metab ,2001,86(12):5658-5671.
  • 7Eng C,Clayton D,Schuffenecker I,et al.The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2.International RET mutation consortium analysis.JAMA ,1996,276(19):1575-1579.
  • 8Zordan P,Tavella S,Brizzolara A,et al.The immediate upstream sequence of the mouse Ret gene controls tissue-specific expression in transgenic mice.Int J Mol Med ,2006,18(4):601-608.
  • 9Hofstra RM,Landsvater RM,Ceccherini I,et al.A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.Nature ,1994,367(6461):375-376.
  • 10Marsh DJ,Learoyd DL,Andrew SD,et al.Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.Clin Endocrinol (Oxf) ,1996,44(3):249-257.

引证文献9

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部